FF:10053-101G8: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity=A | |sample_ethnicity=A | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;7.7158642551264e-268!GO:0005737;cytoplasm;1.73934818645994e-135!GO:0043227;membrane-bound organelle;6.93822804978679e-112!GO:0043231;intracellular membrane-bound organelle;1.19816809166598e-111!GO:0043226;organelle;1.87872797453961e-108!GO:0043229;intracellular organelle;7.4159442124881e-108!GO:0044444;cytoplasmic part;2.98118013339017e-91!GO:0044422;organelle part;1.13244453878336e-74!GO:0044446;intracellular organelle part;3.23789859776292e-73!GO:0032991;macromolecular complex;1.51437390375263e-70!GO:0005515;protein binding;2.92969481169276e-61!GO:0044237;cellular metabolic process;1.8623094595303e-55!GO:0003723;RNA binding;1.10397596837609e-52!GO:0044238;primary metabolic process;5.79749013508163e-52!GO:0043170;macromolecule metabolic process;1.21665784448552e-50!GO:0030529;ribonucleoprotein complex;1.3268340513726e-50!GO:0019538;protein metabolic process;1.53861022713391e-48!GO:0044260;cellular macromolecule metabolic process;1.82058840363366e-46!GO:0044267;cellular protein metabolic process;2.32889966637035e-46!GO:0005634;nucleus;6.81704152053738e-41!GO:0044428;nuclear part;1.13055277520432e-40!GO:0006412;translation;1.61285724071042e-40!GO:0043234;protein complex;1.30007444588405e-39!GO:0005829;cytosol;6.35300098208147e-37!GO:0043233;organelle lumen;6.31419568289306e-36!GO:0031974;membrane-enclosed lumen;6.31419568289306e-36!GO:0005739;mitochondrion;4.97244447686324e-35!GO:0033036;macromolecule localization;7.92833126521561e-35!GO:0031090;organelle membrane;3.99538441412575e-34!GO:0015031;protein transport;5.95230149302536e-34!GO:0045184;establishment of protein localization;3.35609997766847e-33!GO:0005840;ribosome;3.35609997766847e-33!GO:0009059;macromolecule biosynthetic process;8.25555881740947e-33!GO:0008104;protein localization;8.58197322164369e-33!GO:0003735;structural constituent of ribosome;4.34359379821272e-30!GO:0031967;organelle envelope;7.14411617533811e-28!GO:0016071;mRNA metabolic process;8.65549546264765e-28!GO:0031975;envelope;1.29077147791094e-27!GO:0044249;cellular biosynthetic process;2.25933249875644e-27!GO:0009058;biosynthetic process;2.71009845101301e-27!GO:0033279;ribosomal subunit;2.84297483009119e-27!GO:0016043;cellular component organization and biogenesis;4.10109701515282e-26!GO:0012501;programmed cell death;1.60818401478453e-25!GO:0006915;apoptosis;2.02284784529867e-25!GO:0044445;cytosolic part;2.87421367079561e-25!GO:0044429;mitochondrial part;3.23743644580188e-25!GO:0031981;nuclear lumen;4.61090491007198e-25!GO:0008219;cell death;7.43437830226024e-25!GO:0016265;death;7.43437830226024e-25!GO:0006396;RNA processing;2.6197440703201e-24!GO:0065003;macromolecular complex assembly;3.40313267552791e-24!GO:0005830;cytosolic ribosome (sensu Eukaryota);4.99438000179996e-24!GO:0043283;biopolymer metabolic process;1.70961350883918e-23!GO:0008380;RNA splicing;5.15763375185502e-23!GO:0006397;mRNA processing;1.64084491939865e-22!GO:0046907;intracellular transport;4.88844223549277e-22!GO:0006886;intracellular protein transport;9.90542323348647e-21!GO:0022607;cellular component assembly;1.39279643105083e-20!GO:0002376;immune system process;8.24386730231128e-20!GO:0005740;mitochondrial envelope;4.07497027556896e-19!GO:0010467;gene expression;5.51344098710051e-19!GO:0006119;oxidative phosphorylation;1.22548118292184e-18!GO:0031966;mitochondrial membrane;1.95456081036131e-18!GO:0042981;regulation of apoptosis;6.61942844324138e-18!GO:0051641;cellular localization;6.99788945722473e-18!GO:0043412;biopolymer modification;8.65780089602606e-18!GO:0005654;nucleoplasm;8.75341934980562e-18!GO:0043067;regulation of programmed cell death;9.18646450460061e-18!GO:0051649;establishment of cellular localization;1.06347745377631e-17!GO:0019866;organelle inner membrane;1.89145296942575e-17!GO:0000166;nucleotide binding;2.46645656201981e-17!GO:0008134;transcription factor binding;7.37157523416484e-17!GO:0006464;protein modification process;8.02376944475081e-17!GO:0016462;pyrophosphatase activity;1.27420150131439e-16!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;1.27420150131439e-16!GO:0017111;nucleoside-triphosphatase activity;1.45505095694575e-16!GO:0016817;hydrolase activity, acting on acid anhydrides;1.95384672928012e-16!GO:0022613;ribonucleoprotein complex biogenesis and assembly;5.48680220399261e-16!GO:0005681;spliceosome;5.83085576832911e-16!GO:0006512;ubiquitin cycle;1.51299107177049e-15!GO:0005743;mitochondrial inner membrane;1.91979679018863e-15!GO:0043687;post-translational protein modification;2.82099890624977e-15!GO:0006996;organelle organization and biogenesis;6.38152123636902e-15!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;8.66676736572745e-15!GO:0044265;cellular macromolecule catabolic process;9.77125213705729e-15!GO:0015935;small ribosomal subunit;1.44469799443773e-14!GO:0044451;nucleoplasm part;2.32567609286309e-14!GO:0048770;pigment granule;3.70742433063081e-14!GO:0042470;melanosome;3.70742433063081e-14!GO:0022618;protein-RNA complex assembly;5.13389046296753e-14!GO:0006955;immune response;5.76765835393738e-14!GO:0015934;large ribosomal subunit;9.51534663819663e-14!GO:0006259;DNA metabolic process;1.92784935536842e-13!GO:0006793;phosphorus metabolic process;2.65070385592364e-13!GO:0006796;phosphate metabolic process;2.65070385592364e-13!GO:0012505;endomembrane system;3.78328602641154e-13!GO:0032553;ribonucleotide binding;3.79341076683691e-13!GO:0032555;purine ribonucleotide binding;3.79341076683691e-13!GO:0016192;vesicle-mediated transport;4.8077930054092e-13!GO:0044455;mitochondrial membrane part;6.14732487768551e-13!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);6.38060406643169e-13!GO:0005746;mitochondrial respiratory chain;7.89231789821625e-13!GO:0043285;biopolymer catabolic process;1.04244449068846e-12!GO:0007243;protein kinase cascade;1.30118787984743e-12!GO:0006913;nucleocytoplasmic transport;1.31812176605792e-12!GO:0017076;purine nucleotide binding;1.98278309484896e-12!GO:0007242;intracellular signaling cascade;2.50487381896845e-12!GO:0044248;cellular catabolic process;3.36560789208717e-12!GO:0051169;nuclear transport;3.38218464107734e-12!GO:0009057;macromolecule catabolic process;5.60338037849716e-12!GO:0051246;regulation of protein metabolic process;6.26607781171932e-12!GO:0050136;NADH dehydrogenase (quinone) activity;7.79167039561151e-12!GO:0003954;NADH dehydrogenase activity;7.79167039561151e-12!GO:0008137;NADH dehydrogenase (ubiquinone) activity;7.79167039561151e-12!GO:0051603;proteolysis involved in cellular protein catabolic process;8.8269544708487e-12!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);1.10507338088169e-11!GO:0019941;modification-dependent protein catabolic process;1.11003708010223e-11!GO:0043632;modification-dependent macromolecule catabolic process;1.11003708010223e-11!GO:0016310;phosphorylation;1.12670768416609e-11!GO:0006605;protein targeting;1.56682806008945e-11!GO:0016874;ligase activity;1.62677720055523e-11!GO:0044257;cellular protein catabolic process;1.62677720055523e-11!GO:0005794;Golgi apparatus;1.74791741743063e-11!GO:0006511;ubiquitin-dependent protein catabolic process;2.30257758888014e-11!GO:0043228;non-membrane-bound organelle;2.48940731814233e-11!GO:0043232;intracellular non-membrane-bound organelle;2.48940731814233e-11!GO:0051186;cofactor metabolic process;2.57761657029894e-11!GO:0005773;vacuole;4.18489893004795e-11!GO:0007249;I-kappaB kinase/NF-kappaB cascade;7.76304090514106e-11!GO:0043069;negative regulation of programmed cell death;8.91297130885337e-11!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;9.52374560349855e-11!GO:0043066;negative regulation of apoptosis;1.18641221197062e-10!GO:0008135;translation factor activity, nucleic acid binding;1.70789009097392e-10!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;1.73637660681537e-10!GO:0048523;negative regulation of cellular process;1.97339981834847e-10!GO:0016604;nuclear body;2.75740320849769e-10!GO:0006457;protein folding;3.52624108072985e-10!GO:0005768;endosome;4.73029227923715e-10!GO:0006325;establishment and/or maintenance of chromatin architecture;5.21652253044982e-10!GO:0006916;anti-apoptosis;5.24989691955156e-10!GO:0000323;lytic vacuole;5.24989691955156e-10!GO:0005764;lysosome;5.24989691955156e-10!GO:0042775;organelle ATP synthesis coupled electron transport;5.24989691955156e-10!GO:0042773;ATP synthesis coupled electron transport;5.24989691955156e-10!GO:0065009;regulation of a molecular function;9.19191545850456e-10!GO:0005635;nuclear envelope;9.42459854509938e-10!GO:0003712;transcription cofactor activity;1.02432488557964e-09!GO:0008639;small protein conjugating enzyme activity;1.04055469133705e-09!GO:0030964;NADH dehydrogenase complex (quinone);1.19596192175737e-09!GO:0045271;respiratory chain complex I;1.19596192175737e-09!GO:0005747;mitochondrial respiratory chain complex I;1.19596192175737e-09!GO:0000502;proteasome complex (sensu Eukaryota);1.33369233306865e-09!GO:0016787;hydrolase activity;1.38171305111533e-09!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;1.64523761018091e-09!GO:0005783;endoplasmic reticulum;1.85463034269228e-09!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;2.00184608315404e-09!GO:0006323;DNA packaging;2.03472918246042e-09!GO:0004842;ubiquitin-protein ligase activity;2.63568536198671e-09!GO:0006413;translational initiation;2.63568536198671e-09!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;2.85974823915603e-09!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;3.78617767637364e-09!GO:0019829;cation-transporting ATPase activity;4.02792897807071e-09!GO:0000398;nuclear mRNA splicing, via spliceosome;4.07185407832934e-09!GO:0000375;RNA splicing, via transesterification reactions;4.07185407832934e-09!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;4.07185407832934e-09!GO:0016887;ATPase activity;6.16266512516346e-09!GO:0005524;ATP binding;6.69047845620523e-09!GO:0032559;adenyl ribonucleotide binding;8.20144772800613e-09!GO:0019787;small conjugating protein ligase activity;8.41358850024889e-09!GO:0006366;transcription from RNA polymerase II promoter;8.77055824601171e-09!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;8.98563039526254e-09!GO:0048519;negative regulation of biological process;9.33571381826223e-09!GO:0031980;mitochondrial lumen;9.66419251281898e-09!GO:0005759;mitochondrial matrix;9.66419251281898e-09!GO:0009150;purine ribonucleotide metabolic process;1.08060610001869e-08!GO:0003924;GTPase activity;1.12360592112462e-08!GO:0030163;protein catabolic process;1.2426965035029e-08!GO:0042623;ATPase activity, coupled;1.27121410683258e-08!GO:0003743;translation initiation factor activity;1.28387834055494e-08!GO:0009615;response to virus;1.83011983892912e-08!GO:0048193;Golgi vesicle transport;2.2674747300366e-08!GO:0009259;ribonucleotide metabolic process;2.60985102628727e-08!GO:0006163;purine nucleotide metabolic process;2.66031587358439e-08!GO:0009152;purine ribonucleotide biosynthetic process;2.79494921472917e-08!GO:0006446;regulation of translational initiation;3.17141356953723e-08!GO:0005770;late endosome;3.7627833310481e-08!GO:0030554;adenyl nucleotide binding;3.83357204450001e-08!GO:0015986;ATP synthesis coupled proton transport;4.05767707087679e-08!GO:0015985;energy coupled proton transport, down electrochemical gradient;4.05767707087679e-08!GO:0006950;response to stress;4.75381673396246e-08!GO:0017038;protein import;5.13398290569427e-08!GO:0006732;coenzyme metabolic process;6.62881251363309e-08!GO:0031965;nuclear membrane;7.12435184972795e-08!GO:0006164;purine nucleotide biosynthetic process;7.58934688972645e-08!GO:0051276;chromosome organization and biogenesis;8.67568192861177e-08!GO:0016607;nuclear speck;8.77688106529838e-08!GO:0005730;nucleolus;9.71410463542349e-08!GO:0009205;purine ribonucleoside triphosphate metabolic process;1.24477152407966e-07!GO:0009144;purine nucleoside triphosphate metabolic process;1.24477152407966e-07!GO:0003676;nucleic acid binding;1.61922882876466e-07!GO:0048522;positive regulation of cellular process;1.73421007615105e-07!GO:0051082;unfolded protein binding;1.73421007615105e-07!GO:0009260;ribonucleotide biosynthetic process;1.77764435590753e-07!GO:0045321;leukocyte activation;1.80206459529404e-07!GO:0015078;hydrogen ion transmembrane transporter activity;1.8936570375714e-07!GO:0065004;protein-DNA complex assembly;1.96865798304794e-07!GO:0009199;ribonucleoside triphosphate metabolic process;1.99527470922584e-07!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;2.08925607613095e-07!GO:0009145;purine nucleoside triphosphate biosynthetic process;2.08925607613095e-07!GO:0043065;positive regulation of apoptosis;2.17898073878248e-07!GO:0046034;ATP metabolic process;2.59353777585153e-07!GO:0043068;positive regulation of programmed cell death;2.62715363763344e-07!GO:0051170;nuclear import;2.72706837139233e-07!GO:0005525;GTP binding;2.73643144895512e-07!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;2.73989588253031e-07!GO:0051726;regulation of cell cycle;2.74943404846533e-07!GO:0006754;ATP biosynthetic process;3.12338441691802e-07!GO:0006753;nucleoside phosphate metabolic process;3.12338441691802e-07!GO:0009142;nucleoside triphosphate biosynthetic process;3.50595853729073e-07!GO:0009201;ribonucleoside triphosphate biosynthetic process;3.50595853729073e-07!GO:0009141;nucleoside triphosphate metabolic process;3.58586610666225e-07!GO:0006606;protein import into nucleus;3.69913072829244e-07!GO:0016881;acid-amino acid ligase activity;3.9570751804925e-07!GO:0048518;positive regulation of biological process;4.35336461506052e-07!GO:0009056;catabolic process;4.35336461506052e-07!GO:0000074;regulation of progression through cell cycle;4.37097342101742e-07!GO:0006417;regulation of translation;4.42465730201511e-07!GO:0016469;proton-transporting two-sector ATPase complex;4.66205981663329e-07!GO:0005761;mitochondrial ribosome;5.92063921262927e-07!GO:0000313;organellar ribosome;5.92063921262927e-07!GO:0044432;endoplasmic reticulum part;6.68235079767608e-07!GO:0003713;transcription coactivator activity;7.9074320882561e-07!GO:0019899;enzyme binding;8.80285375461356e-07!GO:0050790;regulation of catalytic activity;8.80285375461356e-07!GO:0007264;small GTPase mediated signal transduction;1.13062875562835e-06!GO:0006333;chromatin assembly or disassembly;1.18723648569779e-06!GO:0044453;nuclear membrane part;1.36309377186267e-06!GO:0045786;negative regulation of progression through cell cycle;1.40307050231557e-06!GO:0006917;induction of apoptosis;1.42105714224356e-06!GO:0008632;apoptotic program;1.51826073292751e-06!GO:0001775;cell activation;1.54825383268165e-06!GO:0007049;cell cycle;1.65590878661012e-06!GO:0046649;lymphocyte activation;2.12859794880886e-06!GO:0009060;aerobic respiration;2.12859794880886e-06!GO:0012502;induction of programmed cell death;2.18684689485601e-06!GO:0016568;chromatin modification;2.42447051287604e-06!GO:0009967;positive regulation of signal transduction;2.59911397948467e-06!GO:0032446;protein modification by small protein conjugation;3.12709745424855e-06!GO:0005839;proteasome core complex (sensu Eukaryota);3.34838350591958e-06!GO:0016879;ligase activity, forming carbon-nitrogen bonds;3.45094386701647e-06!GO:0030097;hemopoiesis;3.51613031620287e-06!GO:0031326;regulation of cellular biosynthetic process;3.51613031620287e-06!GO:0005774;vacuolar membrane;3.56694607216294e-06!GO:0006461;protein complex assembly;3.71874177296421e-06!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;3.77557904721635e-06!GO:0015077;monovalent inorganic cation transmembrane transporter activity;3.8467694295126e-06!GO:0001772;immunological synapse;4.12317076362492e-06!GO:0032561;guanyl ribonucleotide binding;4.14760886503247e-06!GO:0019001;guanyl nucleotide binding;4.14760886503247e-06!GO:0009117;nucleotide metabolic process;4.31634517093759e-06!GO:0016567;protein ubiquitination;4.47354440688465e-06!GO:0005793;ER-Golgi intermediate compartment;4.78363410944776e-06!GO:0050794;regulation of cellular process;5.44754869511681e-06!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;5.5461896216292e-06!GO:0015399;primary active transmembrane transporter activity;5.5461896216292e-06!GO:0000151;ubiquitin ligase complex;5.9185736569568e-06!GO:0051188;cofactor biosynthetic process;6.19758366538845e-06!GO:0044440;endosomal part;6.78584937517933e-06!GO:0010008;endosome membrane;6.78584937517933e-06!GO:0006334;nucleosome assembly;7.54570639503716e-06!GO:0000785;chromatin;7.74064652885805e-06!GO:0043492;ATPase activity, coupled to movement of substances;8.65649002425892e-06!GO:0042175;nuclear envelope-endoplasmic reticulum network;8.65649002425892e-06!GO:0016563;transcription activator activity;1.00695178056407e-05!GO:0005789;endoplasmic reticulum membrane;1.03865054568455e-05!GO:0016564;transcription repressor activity;1.11351223065134e-05!GO:0006974;response to DNA damage stimulus;1.13992216684658e-05!GO:0008565;protein transporter activity;1.14220156573757e-05!GO:0044437;vacuolar part;1.14317748652514e-05!GO:0043566;structure-specific DNA binding;1.29713123428649e-05!GO:0005765;lysosomal membrane;1.31720223770541e-05!GO:0045333;cellular respiration;1.38481955452518e-05!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;1.38832851702331e-05!GO:0030532;small nuclear ribonucleoprotein complex;1.38832851702331e-05!GO:0030218;erythrocyte differentiation;1.4271730523321e-05!GO:0042110;T cell activation;1.50105449324498e-05!GO:0045259;proton-transporting ATP synthase complex;1.61176261899e-05!GO:0009055;electron carrier activity;1.67619752232685e-05!GO:0060090;molecular adaptor activity;2.20700987738726e-05!GO:0004298;threonine endopeptidase activity;2.21899709289473e-05!GO:0044431;Golgi apparatus part;2.26106661911443e-05!GO:0009889;regulation of biosynthetic process;2.39436426374678e-05!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;2.4573450050923e-05!GO:0002764;immune response-regulating signal transduction;2.97707176139929e-05!GO:0016070;RNA metabolic process;3.0499549555653e-05!GO:0031902;late endosome membrane;3.6960877066069e-05!GO:0031497;chromatin assembly;3.77869652453675e-05!GO:0009607;response to biotic stimulus;3.81799986003029e-05!GO:0002757;immune response-activating signal transduction;4.05674581887982e-05!GO:0031324;negative regulation of cellular metabolic process;4.35879948333661e-05!GO:0008047;enzyme activator activity;4.79892812447251e-05!GO:0016772;transferase activity, transferring phosphorus-containing groups;5.07224168896938e-05!GO:0030120;vesicle coat;5.07224168896938e-05!GO:0030662;coated vesicle membrane;5.07224168896938e-05!GO:0006099;tricarboxylic acid cycle;5.07224168896938e-05!GO:0046356;acetyl-CoA catabolic process;5.07224168896938e-05!GO:0005643;nuclear pore;5.32908044340897e-05!GO:0002520;immune system development;5.33114606366587e-05!GO:0003697;single-stranded DNA binding;6.25091442018273e-05!GO:0048468;cell development;7.18522783324814e-05!GO:0050657;nucleic acid transport;7.21606532885e-05!GO:0051236;establishment of RNA localization;7.21606532885e-05!GO:0050658;RNA transport;7.21606532885e-05!GO:0002768;immune response-regulating cell surface receptor signaling pathway;7.91085388818571e-05!GO:0006403;RNA localization;8.02989878885645e-05!GO:0000245;spliceosome assembly;8.16541290427402e-05!GO:0031982;vesicle;8.51153693877506e-05!GO:0051187;cofactor catabolic process;9.68886532760909e-05!GO:0016740;transferase activity;0.000100453941648871!GO:0002429;immune response-activating cell surface receptor signaling pathway;0.000106996851670787!GO:0030099;myeloid cell differentiation;0.000109336864783986!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;0.00011083415112577!GO:0006613;cotranslational protein targeting to membrane;0.000113503149944384!GO:0008026;ATP-dependent helicase activity;0.000127257184155772!GO:0006084;acetyl-CoA metabolic process;0.000133024445002194!GO:0009892;negative regulation of metabolic process;0.000159815947196431!GO:0046930;pore complex;0.000166924545690603!GO:0018193;peptidyl-amino acid modification;0.000183454258515979!GO:0048534;hemopoietic or lymphoid organ development;0.000190519733826497!GO:0006401;RNA catabolic process;0.000204160965073335!GO:0051336;regulation of hydrolase activity;0.000212041352486163!GO:0050789;regulation of biological process;0.000217946829187585!GO:0048475;coated membrane;0.000232687012975789!GO:0030117;membrane coat;0.000232687012975789!GO:0005885;Arp2/3 protein complex;0.000243455607325689!GO:0051168;nuclear export;0.000245913111322896!GO:0051251;positive regulation of lymphocyte activation;0.000261256109546156!GO:0009109;coenzyme catabolic process;0.000266606143749646!GO:0006752;group transfer coenzyme metabolic process;0.000270779349597626!GO:0022402;cell cycle process;0.000288205834479889!GO:0007265;Ras protein signal transduction;0.000289412902599153!GO:0016197;endosome transport;0.000298829431031477!GO:0005694;chromosome;0.000303504633710467!GO:0004386;helicase activity;0.00031217760863766!GO:0009108;coenzyme biosynthetic process;0.000317079479052594!GO:0004674;protein serine/threonine kinase activity;0.000327573825376742!GO:0032940;secretion by cell;0.000345162021763613!GO:0031410;cytoplasmic vesicle;0.000357542212051471!GO:0003729;mRNA binding;0.000364137202000916!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.000382842056014863!GO:0022890;inorganic cation transmembrane transporter activity;0.00039720785278424!GO:0006818;hydrogen transport;0.000402204331644381!GO:0042101;T cell receptor complex;0.000406208042842004!GO:0003714;transcription corepressor activity;0.000418942015181641!GO:0031988;membrane-bound vesicle;0.000418942015181641!GO:0006888;ER to Golgi vesicle-mediated transport;0.000431607360465798!GO:0031252;leading edge;0.000454067326220419!GO:0015992;proton transport;0.000460141749631756!GO:0042254;ribosome biogenesis and assembly;0.000488676460111483!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.000499279994763321!GO:0000139;Golgi membrane;0.000527395785225612!GO:0006281;DNA repair;0.000546550912157617!GO:0044427;chromosomal part;0.000586853568326949!GO:0002252;immune effector process;0.000630893931045511!GO:0016481;negative regulation of transcription;0.000651175281311223!GO:0005070;SH3/SH2 adaptor activity;0.000671170513882055!GO:0006612;protein targeting to membrane;0.00068219569323641!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.000718551842759953!GO:0051028;mRNA transport;0.000767500848663614!GO:0051707;response to other organism;0.000780580023999933!GO:0005798;Golgi-associated vesicle;0.000798261067620002!GO:0009966;regulation of signal transduction;0.000798261067620002!GO:0065007;biological regulation;0.000823430550848787!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.000846175570164363!GO:0030695;GTPase regulator activity;0.000880319778871552!GO:0022415;viral reproductive process;0.000925857810224796!GO:0006402;mRNA catabolic process;0.000939682658520066!GO:0016044;membrane organization and biogenesis;0.0010120760803373!GO:0016023;cytoplasmic membrane-bound vesicle;0.00102792825530595!GO:0002443;leukocyte mediated immunity;0.00104958771274401!GO:0005769;early endosome;0.00109234020258834!GO:0051427;hormone receptor binding;0.00116305056836787!GO:0046822;regulation of nucleocytoplasmic transport;0.00116963551088687!GO:0043623;cellular protein complex assembly;0.00118712563186886!GO:0006650;glycerophospholipid metabolic process;0.00122421266186851!GO:0005762;mitochondrial large ribosomal subunit;0.00133266354112461!GO:0000315;organellar large ribosomal subunit;0.00133266354112461!GO:0045045;secretory pathway;0.00133606759426952!GO:0005057;receptor signaling protein activity;0.00135382372183921!GO:0030041;actin filament polymerization;0.00135615999144468!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.00135756690391072!GO:0000786;nucleosome;0.00136753197726158!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00142855861556686!GO:0050851;antigen receptor-mediated signaling pathway;0.0015516633313894!GO:0005667;transcription factor complex;0.00156444007871958!GO:0006611;protein export from nucleus;0.0016247554883705!GO:0043281;regulation of caspase activity;0.00166310859010996!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.00166310859010996!GO:0044262;cellular carbohydrate metabolic process;0.0017317216504933!GO:0016791;phosphoric monoester hydrolase activity;0.00175367534239529!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00179185554094262!GO:0009719;response to endogenous stimulus;0.00183768022210278!GO:0035257;nuclear hormone receptor binding;0.00191457990062509!GO:0008654;phospholipid biosynthetic process;0.00192441834052085!GO:0005741;mitochondrial outer membrane;0.00196952306590423!GO:0007034;vacuolar transport;0.00215491579812004!GO:0008637;apoptotic mitochondrial changes;0.00234762225931711!GO:0030036;actin cytoskeleton organization and biogenesis;0.00238030937927363!GO:0043488;regulation of mRNA stability;0.00257994781180297!GO:0043487;regulation of RNA stability;0.00257994781180297!GO:0006919;caspase activation;0.00272872110792952!GO:0019867;outer membrane;0.00291904329779883!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00298341129418358!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00298341129418358!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00298341129418358!GO:0065002;intracellular protein transport across a membrane;0.00298341129418358!GO:0005083;small GTPase regulator activity;0.00301289334161985!GO:0031072;heat shock protein binding;0.0031074815485042!GO:0051090;regulation of transcription factor activity;0.00323846884662131!GO:0006091;generation of precursor metabolites and energy;0.00324236396322949!GO:0003725;double-stranded RNA binding;0.00326053895649404!GO:0007050;cell cycle arrest;0.00328680517919205!GO:0006468;protein amino acid phosphorylation;0.00332641926281509!GO:0005096;GTPase activator activity;0.00340304889735879!GO:0031968;organelle outer membrane;0.00344090837035013!GO:0042113;B cell activation;0.00345021354235632!GO:0001816;cytokine production;0.00345966484994428!GO:0002504;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;0.00356390856747928!GO:0050870;positive regulation of T cell activation;0.00364483613238329!GO:0051338;regulation of transferase activity;0.00366890469285922!GO:0005852;eukaryotic translation initiation factor 3 complex;0.00373002394657997!GO:0048250;mitochondrial iron ion transport;0.00373451733125058!GO:0051252;regulation of RNA metabolic process;0.00396734586179074!GO:0000287;magnesium ion binding;0.00396734586179074!GO:0042802;identical protein binding;0.00422886897302137!GO:0008154;actin polymerization and/or depolymerization;0.00428466645102014!GO:0016779;nucleotidyltransferase activity;0.00431382511506788!GO:0005637;nuclear inner membrane;0.00431382511506788!GO:0006891;intra-Golgi vesicle-mediated transport;0.00443859132038692!GO:0004715;non-membrane spanning protein tyrosine kinase activity;0.00449221381988115!GO:0019843;rRNA binding;0.00450268820645711!GO:0007005;mitochondrion organization and biogenesis;0.00465802935589169!GO:0002274;myeloid leukocyte activation;0.00508410237742937!GO:0003724;RNA helicase activity;0.00539266615240846!GO:0042287;MHC protein binding;0.00539266615240846!GO:0043549;regulation of kinase activity;0.00539266615240846!GO:0009165;nucleotide biosynthetic process;0.0056195243588804!GO:0009893;positive regulation of metabolic process;0.0056195243588804!GO:0050811;GABA receptor binding;0.00563743472629847!GO:0019904;protein domain specific binding;0.00566837712276824!GO:0046456;icosanoid biosynthetic process;0.00579289670411814!GO:0006672;ceramide metabolic process;0.00592666606875154!GO:0043280;positive regulation of caspase activity;0.00599289651891787!GO:0033116;ER-Golgi intermediate compartment membrane;0.00604665009660468!GO:0043085;positive regulation of catalytic activity;0.00610073720659828!GO:0003690;double-stranded DNA binding;0.00610073720659828!GO:0008234;cysteine-type peptidase activity;0.00694420697877538!GO:0002521;leukocyte differentiation;0.00694420697877538!GO:0043235;receptor complex;0.00710311509065602!GO:0002682;regulation of immune system process;0.00739010820781288!GO:0051223;regulation of protein transport;0.00766279680026353!GO:0042168;heme metabolic process;0.00787301695501216!GO:0030384;phosphoinositide metabolic process;0.00800862220604872!GO:0046519;sphingoid metabolic process;0.00842417392030197!GO:0016072;rRNA metabolic process;0.00843835478805617!GO:0002253;activation of immune response;0.00847899077630173!GO:0051092;activation of NF-kappaB transcription factor;0.00866149074812292!GO:0045859;regulation of protein kinase activity;0.00886701270058208!GO:0051920;peroxiredoxin activity;0.00890459747640829!GO:0007041;lysosomal transport;0.00890459747640829!GO:0005813;centrosome;0.0089048182960286!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;0.00898601898316443!GO:0004812;aminoacyl-tRNA ligase activity;0.00898601898316443!GO:0016875;ligase activity, forming carbon-oxygen bonds;0.00898601898316443!GO:0006607;NLS-bearing substrate import into nucleus;0.00951479695667085!GO:0016311;dephosphorylation;0.00956226942884674!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0095968345536379!GO:0002449;lymphocyte mediated immunity;0.0096480381112557!GO:0030176;integral to endoplasmic reticulum membrane;0.00996267752847969!GO:0045454;cell redox homeostasis;0.00996267752847969!GO:0050865;regulation of cell activation;0.0101538367529712!GO:0006778;porphyrin metabolic process;0.0101700992866036!GO:0033013;tetrapyrrole metabolic process;0.0101700992866036!GO:0045121;lipid raft;0.0102938962369322!GO:0045576;mast cell activation;0.0103728841891!GO:0030658;transport vesicle membrane;0.0104713751822569!GO:0016301;kinase activity;0.0105697985818647!GO:0051249;regulation of lymphocyte activation;0.0105697985818647!GO:0047485;protein N-terminus binding;0.010805761728861!GO:0015980;energy derivation by oxidation of organic compounds;0.010805761728861!GO:0016773;phosphotransferase activity, alcohol group as acceptor;0.0110049233218198!GO:0043299;leukocyte degranulation;0.0110867384530367!GO:0046983;protein dimerization activity;0.011146856431406!GO:0048487;beta-tubulin binding;0.0112049494625496!GO:0004177;aminopeptidase activity;0.0113399296440121!GO:0019210;kinase inhibitor activity;0.0113945990467761!GO:0050871;positive regulation of B cell activation;0.0114388898409961!GO:0019079;viral genome replication;0.0119853037919857!GO:0051345;positive regulation of hydrolase activity;0.0119998951010248!GO:0043506;regulation of JNK activity;0.0122281811803984!GO:0043021;ribonucleoprotein binding;0.0122890013940594!GO:0006364;rRNA processing;0.0123645277970657!GO:0001516;prostaglandin biosynthetic process;0.0124426320392808!GO:0046457;prostanoid biosynthetic process;0.0124426320392808!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0124426320392808!GO:0015002;heme-copper terminal oxidase activity;0.0124426320392808!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0124426320392808!GO:0004129;cytochrome-c oxidase activity;0.0124426320392808!GO:0006643;membrane lipid metabolic process;0.0124860199920398!GO:0042613;MHC class II protein complex;0.0124860199920398!GO:0019221;cytokine and chemokine mediated signaling pathway;0.0124975679205108!GO:0004185;serine carboxypeptidase activity;0.0127702325543392!GO:0002474;antigen processing and presentation of peptide antigen via MHC class I;0.0128469998203428!GO:0045058;T cell selection;0.0129347453478257!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.0137685416444514!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.0137685416444514!GO:0004860;protein kinase inhibitor activity;0.0140154381102074!GO:0031625;ubiquitin protein ligase binding;0.0145127800109565!GO:0046474;glycerophospholipid biosynthetic process;0.0145483746280142!GO:0033157;regulation of intracellular protein transport;0.014626667838834!GO:0042306;regulation of protein import into nucleus;0.014626667838834!GO:0004722;protein serine/threonine phosphatase activity;0.0147574016706094!GO:0002250;adaptive immune response;0.0147574016706094!GO:0002460;adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;0.0147574016706094!GO:0019058;viral infectious cycle;0.0148742182355366!GO:0001836;release of cytochrome c from mitochondria;0.014924946117065!GO:0045113;regulation of integrin biosynthetic process;0.0151038432139358!GO:0045112;integrin biosynthetic process;0.0151038432139358!GO:0007040;lysosome organization and biogenesis;0.015185899511393!GO:0006595;polyamine metabolic process;0.0156160134490704!GO:0043038;amino acid activation;0.0158697510945516!GO:0006418;tRNA aminoacylation for protein translation;0.0158697510945516!GO:0043039;tRNA aminoacylation;0.0158697510945516!GO:0048500;signal recognition particle;0.0163587847316504!GO:0050776;regulation of immune response;0.0165054783578647!GO:0002684;positive regulation of immune system process;0.0165116525086048!GO:0004197;cysteine-type endopeptidase activity;0.0165116525086048!GO:0000118;histone deacetylase complex;0.0167254861456365!GO:0043300;regulation of leukocyte degranulation;0.0167930471523647!GO:0030217;T cell differentiation;0.0172465640235316!GO:0001819;positive regulation of cytokine production;0.0176468744540976!GO:0001726;ruffle;0.0184103829468679!GO:0051098;regulation of binding;0.0184369171344142!GO:0043087;regulation of GTPase activity;0.0184369171344142!GO:0006213;pyrimidine nucleoside metabolic process;0.0187374220247031!GO:0045892;negative regulation of transcription, DNA-dependent;0.0187863302921331!GO:0045653;negative regulation of megakaryocyte differentiation;0.0188449489946183!GO:0006740;NADPH regeneration;0.0201502317460739!GO:0006098;pentose-phosphate shunt;0.0201502317460739!GO:0006783;heme biosynthetic process;0.0202812212909771!GO:0017166;vinculin binding;0.0206873194360251!GO:0048471;perinuclear region of cytoplasm;0.020727037757636!GO:0016363;nuclear matrix;0.020727037757636!GO:0008629;induction of apoptosis by intracellular signals;0.020727037757636!GO:0030660;Golgi-associated vesicle membrane;0.0208100954125951!GO:0030029;actin filament-based process;0.0208961868397142!GO:0030098;lymphocyte differentiation;0.0211842161204345!GO:0008624;induction of apoptosis by extracellular signals;0.0212245860305562!GO:0006414;translational elongation;0.0219381051661927!GO:0000314;organellar small ribosomal subunit;0.0219381051661927!GO:0005763;mitochondrial small ribosomal subunit;0.0219381051661927!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.0219381051661927!GO:0051881;regulation of mitochondrial membrane potential;0.0223925444962171!GO:0006968;cellular defense response;0.0224856879477763!GO:0002444;myeloid leukocyte mediated immunity;0.0231532592482698!GO:0019220;regulation of phosphate metabolic process;0.0237119641562709!GO:0051174;regulation of phosphorus metabolic process;0.0237119641562709!GO:0030137;COPI-coated vesicle;0.0237791154507805!GO:0050778;positive regulation of immune response;0.0247200776327079!GO:0000209;protein polyubiquitination;0.024743138446989!GO:0030663;COPI coated vesicle membrane;0.0247809978845709!GO:0030126;COPI vesicle coat;0.0247809978845709!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.0248615985160233!GO:0019222;regulation of metabolic process;0.0248615985160233!GO:0030132;clathrin coat of coated pit;0.0250736296511716!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.0250803323078283!GO:0045047;protein targeting to ER;0.0250803323078283!GO:0006914;autophagy;0.0250803323078283!GO:0019864;IgG binding;0.0250803323078283!GO:0006897;endocytosis;0.0251286269388426!GO:0010324;membrane invagination;0.0251286269388426!GO:0016505;apoptotic protease activator activity;0.0254832588759739!GO:0051049;regulation of transport;0.0254985412427534!GO:0005521;lamin binding;0.0258644575185363!GO:0051091;positive regulation of transcription factor activity;0.0258644575185363!GO:0008139;nuclear localization sequence binding;0.0259162434520267!GO:0008333;endosome to lysosome transport;0.0262258352489338!GO:0006779;porphyrin biosynthetic process;0.0263116762104642!GO:0033014;tetrapyrrole biosynthetic process;0.0263116762104642!GO:0051789;response to protein stimulus;0.0263386145306749!GO:0006986;response to unfolded protein;0.0263386145306749!GO:0032763;regulation of mast cell cytokine production;0.0263386145306749!GO:0032762;mast cell cytokine production;0.0263386145306749!GO:0008287;protein serine/threonine phosphatase complex;0.0263586753560844!GO:0006979;response to oxidative stress;0.0263780808459629!GO:0030027;lamellipodium;0.0266557785791633!GO:0002448;mast cell mediated immunity;0.026858693590267!GO:0043303;mast cell degranulation;0.026858693590267!GO:0001817;regulation of cytokine production;0.0272092256185772!GO:0016605;PML body;0.0273019371094679!GO:0015923;mannosidase activity;0.0276341621160943!GO:0030674;protein binding, bridging;0.0278099303317058!GO:0050671;positive regulation of lymphocyte proliferation;0.0278099303317058!GO:0032946;positive regulation of mononuclear cell proliferation;0.0278099303317058!GO:0008312;7S RNA binding;0.0280071544447534!GO:0008286;insulin receptor signaling pathway;0.0280071544447534!GO:0031325;positive regulation of cellular metabolic process;0.0280071544447534!GO:0008186;RNA-dependent ATPase activity;0.028167978120766!GO:0016584;nucleosome positioning;0.0283189268362463!GO:0050863;regulation of T cell activation;0.0284026002396812!GO:0005684;U2-dependent spliceosome;0.0286872729784629!GO:0006260;DNA replication;0.0289438661909534!GO:0004721;phosphoprotein phosphatase activity;0.0290742388225707!GO:0031901;early endosome membrane;0.0292962714185968!GO:0043433;negative regulation of transcription factor activity;0.02930315658593!GO:0045926;negative regulation of growth;0.0296629257964722!GO:0016853;isomerase activity;0.0302435675606804!GO:0051235;maintenance of localization;0.0308366303793129!GO:0006376;mRNA splice site selection;0.0320538228265273!GO:0000389;nuclear mRNA 3'-splice site recognition;0.0320538228265273!GO:0042990;regulation of transcription factor import into nucleus;0.0325352791432651!GO:0042991;transcription factor import into nucleus;0.0325352791432651!GO:0007033;vacuole organization and biogenesis;0.0326124133856523!GO:0009116;nucleoside metabolic process;0.032832952372067!GO:0045603;positive regulation of endothelial cell differentiation;0.032832952372067!GO:0006952;defense response;0.0328374683401409!GO:0002822;regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains.;0.0330858024634668!GO:0002819;regulation of adaptive immune response;0.0330858024634668!GO:0045637;regulation of myeloid cell differentiation;0.0339319451672539!GO:0006470;protein amino acid dephosphorylation;0.0340616334716077!GO:0000303;response to superoxide;0.0352524507946546!GO:0030867;rough endoplasmic reticulum membrane;0.0353282673642676!GO:0048821;erythrocyte development;0.0355040740750204!GO:0000082;G1/S transition of mitotic cell cycle;0.0355040740750204!GO:0046489;phosphoinositide biosynthetic process;0.035521589386349!GO:0005791;rough endoplasmic reticulum;0.0359028620565757!GO:0050853;B cell receptor signaling pathway;0.0365686423151744!GO:0005815;microtubule organizing center;0.0372920408420208!GO:0043621;protein self-association;0.0372920408420208!GO:0046467;membrane lipid biosynthetic process;0.0383463068822893!GO:0004437;inositol or phosphatidylinositol phosphatase activity;0.0384269321739248!GO:0019883;antigen processing and presentation of endogenous antigen;0.0387259666394374!GO:0006644;phospholipid metabolic process;0.0393296454296421!GO:0005062;hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity;0.039582363872037!GO:0045792;negative regulation of cell size;0.0395835167146201!GO:0006352;transcription initiation;0.0398994220542935!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0402325042879162!GO:0006289;nucleotide-excision repair;0.0403553188494565!GO:0030258;lipid modification;0.0405579071553848!GO:0006690;icosanoid metabolic process;0.0405819314452716!GO:0004428;inositol or phosphatidylinositol kinase activity;0.0410571335864975!GO:0030145;manganese ion binding;0.0410901307013984!GO:0006458;'de novo' protein folding;0.0414120099373827!GO:0051084;'de novo' posttranslational protein folding;0.0414120099373827!GO:0016491;oxidoreductase activity;0.0415960769546844!GO:0030518;steroid hormone receptor signaling pathway;0.0424500430411141!GO:0043304;regulation of mast cell degranulation;0.0424839290115479!GO:0045309;protein phosphorylated amino acid binding;0.0424839290115479!GO:0043022;ribosome binding;0.0431659670041869!GO:0046966;thyroid hormone receptor binding;0.0433389623857698!GO:0051329;interphase of mitotic cell cycle;0.0436469322949608!GO:0002440;production of molecular mediator of immune response;0.043827706037021!GO:0030308;negative regulation of cell growth;0.04436768815355!GO:0007259;JAK-STAT cascade;0.0451649260771848!GO:0019318;hexose metabolic process;0.0455433746879737!GO:0045646;regulation of erythrocyte differentiation;0.0457362638310909!GO:0043507;positive regulation of JNK activity;0.0470810926026181!GO:0045069;regulation of viral genome replication;0.0487677298268369!GO:0000278;mitotic cell cycle;0.049125527093242!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0491916294565304!GO:0002218;activation of innate immune response;0.0491916294565304!GO:0002758;innate immune response-activating signal transduction;0.0491916294565304!GO:0001784;phosphotyrosine binding;0.0493720770440042!GO:0042288;MHC class I protein binding;0.0497934488109165 | |||
|sample_id=10053 | |sample_id=10053 | ||
|sample_note= | |sample_note= |
Revision as of 16:55, 25 June 2012
Name: | blood, adult, pool1 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11761
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11761
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.103 |
10 | 10 | 0.0726 |
100 | 100 | 0.92 |
101 | 101 | 0.256 |
102 | 102 | 0.707 |
103 | 103 | 0.103 |
104 | 104 | 0.953 |
105 | 105 | 0.0977 |
106 | 106 | 0.00204 |
107 | 107 | 0.18 |
108 | 108 | 0.946 |
109 | 109 | 0.128 |
11 | 11 | 0.0595 |
110 | 110 | 0.606 |
111 | 111 | 0.238 |
112 | 112 | 0.0968 |
113 | 113 | 0.174 |
114 | 114 | 0.0428 |
115 | 115 | 0.439 |
116 | 116 | 0.504 |
117 | 117 | 0.0839 |
118 | 118 | 0.705 |
119 | 119 | 0.255 |
12 | 12 | 0.619 |
120 | 120 | 0.657 |
121 | 121 | 0.498 |
122 | 122 | 0.514 |
123 | 123 | 0.0101 |
124 | 124 | 0.109 |
125 | 125 | 0.0235 |
126 | 126 | 0.359 |
127 | 127 | 0.17 |
128 | 128 | 0.025 |
129 | 129 | 0.582 |
13 | 13 | 0.61 |
130 | 130 | 0.334 |
131 | 131 | 0.969 |
132 | 132 | 0.647 |
133 | 133 | 0.328 |
134 | 134 | 0.857 |
135 | 135 | 0.458 |
136 | 136 | 0.79 |
137 | 137 | 0.101 |
138 | 138 | 0.0717 |
139 | 139 | 0.0131 |
14 | 14 | 0.335 |
140 | 140 | 0.0419 |
141 | 141 | 0.481 |
142 | 142 | 0.931 |
143 | 143 | 4.71449e-4 |
144 | 144 | 0.625 |
145 | 145 | 0.232 |
146 | 146 | 0.735 |
147 | 147 | 0.431 |
148 | 148 | 0.082 |
149 | 149 | 0.349 |
15 | 15 | 0.0735 |
150 | 150 | 0.567 |
151 | 151 | 0.19 |
152 | 152 | 0.0805 |
153 | 153 | 0.465 |
154 | 154 | 0.505 |
155 | 155 | 0.147 |
156 | 156 | 0.466 |
157 | 157 | 0.512 |
158 | 158 | 0.281 |
159 | 159 | 0.0502 |
16 | 16 | 0.278 |
160 | 160 | 0.266 |
161 | 161 | 0.301 |
162 | 162 | 0.886 |
163 | 163 | 0.0978 |
164 | 164 | 0.284 |
165 | 165 | 0.335 |
166 | 166 | 0.565 |
167 | 167 | 0.214 |
168 | 168 | 0.197 |
169 | 169 | 0.0177 |
17 | 17 | 0.254 |
18 | 18 | 0.113 |
19 | 19 | 0.212 |
2 | 2 | 0.365 |
20 | 20 | 0.656 |
21 | 21 | 0.596 |
22 | 22 | 0.292 |
23 | 23 | 0.0899 |
24 | 24 | 0.177 |
25 | 25 | 0.333 |
26 | 26 | 0.132 |
27 | 27 | 0.1 |
28 | 28 | 0.755 |
29 | 29 | 0.516 |
3 | 3 | 0.151 |
30 | 30 | 0.838 |
31 | 31 | 0.337 |
32 | 32 | 0.528 |
33 | 33 | 0.641 |
34 | 34 | 0.219 |
35 | 35 | 0.148 |
36 | 36 | 0.203 |
37 | 37 | 0.15 |
38 | 38 | 0.336 |
39 | 39 | 0.896 |
4 | 4 | 0.999 |
40 | 40 | 0.253 |
41 | 41 | 0.126 |
42 | 42 | 0.358 |
43 | 43 | 0.116 |
44 | 44 | 0.176 |
45 | 45 | 0.465 |
46 | 46 | 0.0862 |
47 | 47 | 0.188 |
48 | 48 | 0.239 |
49 | 49 | 0.0828 |
5 | 5 | 0.255 |
50 | 50 | 0.937 |
51 | 51 | 0.312 |
52 | 52 | 0.348 |
53 | 53 | 0.243 |
54 | 54 | 0.256 |
55 | 55 | 0.122 |
56 | 56 | 0.352 |
57 | 57 | 0.349 |
58 | 58 | 0.0837 |
59 | 59 | 0.0715 |
6 | 6 | 0.854 |
60 | 60 | 0.0424 |
61 | 61 | 0.314 |
62 | 62 | 0.0186 |
63 | 63 | 0.334 |
64 | 64 | 0.234 |
65 | 65 | 0.158 |
66 | 66 | 0.59 |
67 | 67 | 0.158 |
68 | 68 | 0.123 |
69 | 69 | 0.2 |
7 | 7 | 0.253 |
70 | 70 | 0.0668 |
71 | 71 | 0.126 |
72 | 72 | 0.385 |
73 | 73 | 0.225 |
74 | 74 | 0.478 |
75 | 75 | 0.0836 |
76 | 76 | 0.594 |
77 | 77 | 0.458 |
78 | 78 | 0.166 |
79 | 79 | 0.94 |
8 | 8 | 0.16 |
80 | 80 | 0.183 |
81 | 81 | 0.187 |
82 | 82 | 0.011 |
83 | 83 | 0.942 |
84 | 84 | 0.449 |
85 | 85 | 0.0181 |
86 | 86 | 0.13 |
87 | 87 | 0.486 |
88 | 88 | 0.994 |
89 | 89 | 0.422 |
9 | 9 | 0.424 |
90 | 90 | 0.0188 |
91 | 91 | 0.178 |
92 | 92 | 0.0268 |
93 | 93 | 0.704 |
94 | 94 | 0.197 |
95 | 95 | 0.495 |
96 | 96 | 0.0782 |
97 | 97 | 0.823 |
98 | 98 | 0.117 |
99 | 99 | 0.531 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs11761
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000004 tissue sample
FF:0000210 human sample
FF:0010053 human blood - adult sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
UBERON: Anatomy
0000468 (multi-cellular organism)
0007023 (adult organism)
0000922 (embryo)
0000178 (blood)
0000926 (mesoderm)
0000479 (tissue)
0004120 (mesoderm-derived structure)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000480 (anatomical group)
0000923 (germ layer)
0002050 (embryonic structure)
0005423 (developing anatomical structure)
0000179 (haemolymphatic fluid)
0000463 (organism substance)
0000467 (anatomical system)
0001062 (anatomical entity)
0005291 (embryonic tissue)
0006598 (presumptive structure)
0002532 (epiblast (generic))
0002390 (hematopoietic system)
0004535 (cardiovascular system)
0002193 (hemolymphoid system)
0003081 (lateral plate mesoderm)
0001009 (circulatory system)
0006603 (presumptive mesoderm)
0003061 (blood island)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA